Furthermore, DAs can normalize the serum prolactin level in patients with non-functioning pituitary adenoma presented with hyperprolactinemia by inhibition of the normal pituitary function, but there is no chance for tumor regression. This evidence concerns the gene PRL and pituitary gland adenoma.